Rheonix Inc, Ithaca, NY, in collaboration with the New York University College of Dentistry (NYUCD), has received funding to develop a diagnostic for Zika virus infection. The $656,414 award is an administrative supplement to an existing small business innovation research (SBIR) phase I/II fast-track grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health.
OSAP Disclaimer | Please notify our webmaster of any problems with this website. OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.